mhealth and wearables: where do we go? - cib pharma · •mhealth can save according to pwc in 2017...

mHealth and wearables: where do we go?

Luc Baert

CEO Medical Web Services05/06/2015 CIB 45+1

Luc Baert

CEO of Medical Web Services

CEO of Medipim

Member of TSC Recip-e

Security consultant Recip-e

IOTInternet

Of

Things

mHealth

Healthcare

eHealth

mHealth

Presentatie Pieter Van Herck (Voka)

Apple Health with IOS 8

Apps by device

Triangle

Any moment, any place

GSM

Tablets

Devices/sensors

Data

Data

Manufacturer

External partner

Care professionals

Service providers

…

Patient

Social health networks

Studie Iminds28/05/2015

http://www.iminds.be/nl/nieuws/20150528_pr_wearables

Wearables / Apps

• Data from specific sensors• Diabetes

• Exercise

• Heart

• …

• Continuous flow of data

Algorithms !!!!

VOKA Health: WHY?

Why?

• The U.S. healthcare system could reduce costs by nearly $200 billion over the next 25 years by using • remote monitoring technology in patients with of congestive heart

failure, chronic obstructive pulmonary disease, and chronic wounds or skin ulcers

Medicine on the Net.

Why?

• mHealth can save according to PWC in 2017 potentially 99 billion in health care spending in the EU.

• The biggest saving • Well-being and prevention (69 billion euros),

• Management / monitoring (32 billion euros).

• The additional personnel costs to support mHealth: 6.2 billion euros.

The big technology companies

https://plus.google.com/+LarryPage/posts/Lh8SKC6sED1

Issues

• Data protection – security

• mHealth role in healthcare systems and equal access

• Interoperability – standardization

• Reimbursement models

• Liability (accuracy)

• Acceptation by HCP

• Poor discoverability

• Unregulated status of health apps

“Mobile medical apps are medical devices that are

• mobile apps,

• meet the definition of a medical device

• are an accessory to a regulated medical device or transform a mobile platform into a regulated medical device.”

http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Guidan

ceDocuments/UCM263366.pdf

Regulation

To do

Legal

1. Dataprotection, privacy and the use of big data

2. (Inter)nationale regulation and liability

Technical

3. Quality, , accessibility and patient safety

4. Technology and interoperability

Financial

5. Financing and business models

Governmental

6. Supportive in mHealth

How can pharma benefit?

• Contraints

• Patent protection expiring

• Absence of novel blockbusters

• Increasing costs R&D

• Intensifying price pressures

Reimbursement ???

Survey: how to connectwith physicians?

What's pharma's impact on the mobile health app space?

Many of them are designed as companion apps for drugs and devices.

Potential for healthcare

• mHealth• Patient-focused healthcare

• Integrated network healthcare

• Shift towards prevention

• More efficient and sustainable healthcare

Technology is enabler!

Studie Iminds 28/05/2015http://www.iminds.be/nl/nieuws/20150528_pr_wearables

Voka health Community: http://www.healthcommunity.be/

White paper Voka: http://www.healthcommunity.be/sites/default/files/u195/Whitepaper%20Health%20Community%20%27mHealth%27_lowres.pdf

luc.baert@pharmaplanet.be

be.linkedin.com/in/lucbaert

@lucbaert

0475/87.98.67

Luc Baert